| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688142A1 Terfenadine carboxylate and the treatment of dermal irritation |
| 08/09/2006 | EP1687307A2 Substituted imidazo ring systems and methods |
| 08/09/2006 | EP1687297A1 Triazine dimers for the treatment of autoimmune diseases |
| 08/09/2006 | EP1687066A2 Methods of modulating immunity |
| 08/09/2006 | EP1687027A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 08/09/2006 | EP1687026A1 Method for the treatment of multiple sclerosis by inhibiting il-17 activity |
| 08/09/2006 | EP1687025A1 Vaccine compositions comprising an interleukin 18 and saponin adjuvant system |
| 08/09/2006 | EP1587812B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 08/09/2006 | EP1560855B1 Polysaccharide of echinacea angustifolia |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1441730B1 Hydrazono-malonitriles |
| 08/09/2006 | EP1423429B1 Antibodies against caspase-8, their preparation and use |
| 08/09/2006 | EP1368015B1 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1315491B1 Use of substituted pyrazoles for the manufacture of a medicament for the treatment of allergies |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
| 08/09/2006 | EP1077722B1 Methods and products for inducing mucosal immunity |
| 08/09/2006 | EP1076553B1 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and uses |
| 08/09/2006 | EP1044014B1 Agent for treating allergic or hypersensitivity condition |
| 08/09/2006 | EP1007092B1 A process for inhibiting complement activation via the alternative pathway |
| 08/09/2006 | EP0877733B1 Process for production of piperidine derivatives |
| 08/09/2006 | CN1816551A Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 08/09/2006 | CN1816523A N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
| 08/09/2006 | CN1814601A Artemisine derivative with immune suppression action and medicinal composition |
| 08/09/2006 | CN1814301A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 08/09/2006 | CN1814162A Pulse-promoting large-volume injecta and preparing method |
| 08/09/2006 | CN1814076A Chinese medicine composition new use |
| 08/09/2006 | CN1813987A Immunoreaction regulator of eliminating skin and mucous membrane irritability |
| 08/09/2006 | CN1813790A Tablet auxiliary product for increase of body immunological competence |
| 08/09/2006 | CN1813788A Achyranthes bidentata polysaccharide injection formulation and its preparing method |
| 08/09/2006 | CN1813787A Composition of ginseng-astragalus polysaccharides and its preparing method |
| 08/09/2006 | CN1813778A Method for preparing baicalin injection |
| 08/09/2006 | CN1813759A Promethazine hydrochloride dropping pill and its preparing method |
| 08/09/2006 | CN1813743A External-use formulation of levocetirizine hydrochloride |
| 08/09/2006 | CN1813742A Decloxizine hydrochloride dropping pill and its preparing method |
| 08/09/2006 | CN1813732A External-use formulation of fexofenadine |
| 08/09/2006 | CN1813731A Terfenadine dropping pill and its preparing method |
| 08/09/2006 | CN1813730A Fexofenadine hydrochloride dropping pill and its preparing method |
| 08/09/2006 | CN1813727A Triprolidine hydrochloride dropping pill and its preparing method |
| 08/09/2006 | CN1813719A Astemizole dropping pill and its preparing method |
| 08/09/2006 | CN1813571A Wild mineral mung bean powder preparation and mung bean orange juice and its processing method |
| 08/09/2006 | CN1813570A Wild mineral bean powder preparation and its processing method |
| 08/09/2006 | CN1268645C Therapeutic compounds comprised of anti-FC receptor binding agents |
| 08/09/2006 | CN1268644C Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline E to its high affinity receptor |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/09/2006 | CN1268337C Desloratadine dry-mixed suspensoid and preparing method thereof |
| 08/09/2006 | CN1268335C Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/09/2006 | CN1268324C Chinese medicinal soft capsule and preparing process thereof |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087726 Anti-interferon-α antibodies |
| 08/08/2006 | US7087712 Peptide for triggering an immune reaction against tumor cells |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087627 Synergistic mixture of vasculation damaging agent such as tubulin binding agent and inhibitor of forming of nitric oxide; antitumor agents; anticancer agents |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087606 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087595 Antihistaminic spiro compounds |
| 08/08/2006 | US7087573 Genetic engineered protein |
| 08/08/2006 | US7087217 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 08/08/2006 | US7087216 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 08/08/2006 | CA2110899C Orally administrable therapeutic proteins and method of making |
| 08/03/2006 | WO2006081280A1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 08/03/2006 | WO2006081276A1 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 08/03/2006 | WO2006081273A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 08/03/2006 | WO2006080757A1 Novel use of ligands specific to fex-2 polypeptide |
| 08/03/2006 | WO2006080581A1 Agent for control of degranulation reaction and cytokine production |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080522A1 Food or drug comprising lactic acid bacterium containing mineral |
| 08/03/2006 | WO2006080519A1 Diamine derivative |
| 08/03/2006 | WO2006080508A1 Transdermal absorption preparation, sheet holding transdermal absorption preparation and transdermal absorption preparation holder |
| 08/03/2006 | WO2006080483A1 Novel dendritic cell membrane molecule and dna encoding the same |
| 08/03/2006 | WO2006080424A1 Low allergen milk obtained using electrical energy |
| 08/03/2006 | WO2006080420A1 Antigen-specific t cell inducer, antibody production inducer, immune enhancer and vaccine |
| 08/03/2006 | WO2006080312A1 Method for producing adsorptive porous body |
| 08/03/2006 | WO2006080287A1 2-azolylimino-1,3-thiazine derivative |
| 08/03/2006 | WO2006080284A1 2-substituted imino-1,3-oxazine derivative |
| 08/03/2006 | WO2006080171A1 Immunopotentiating agent |
| 08/03/2006 | WO2006079291A1 Artificial synthetic single strand deoxynucleotide and vaccine composition thereof and the use |
| 08/03/2006 | WO2006079169A1 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes |
| 08/03/2006 | WO2006061638A3 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 08/03/2006 | WO2006060507A3 Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders |
| 08/03/2006 | WO2006057932A3 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
| 08/03/2006 | WO2006037960A3 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
| 08/03/2006 | WO2006008512A3 Anti-histaminic composition |
| 08/03/2006 | WO2005113011A3 Prodrugs of ion channel modulating compounds and uses thereof |
| 08/03/2006 | WO2005110470A3 Methods and compositions for the modulation of immune responses and autoimmune diseases by activating rp105 (cd180) |
| 08/03/2006 | WO2005110452A3 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFα-RELATED DISORDERS |